Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Disease

After COVID, Texas is less prepared for the next pandemic

Five years after Texas’ first COVID death, the state spends less on public health, vaccination rates have dropped and a distrust of authority has taken hold.

The Texas Tribune

RFK Jr. and beauty influencers are raving about the health benefits of beef tallow. Here's what science says

Experts warn that the stuff is about 50% saturated fat, which raises the risk of high cholesterol and heart disease.

Fortune

Changes to speech and language can help detect Alzheimer’s early – here are five things to look out for

Ten million people are diagnosed with dementia worldwide each year – that’s more than ever. According to the Alzheimer’s Society approximately one million people in the UK are currently living with the disease. Studies predict this figure will rise to 1.6 million people by 2050.

The Conversation

From analysis to the latest developments in health,
read the most diverse news in one place.

Bug drugs: bacteria-based cancer therapies are finally overcoming barriers

Imagine a world where bacteria, typically feared for causing disease, are turned into powerful weapons against cancer. That’s exactly what some scientists are working on. And they are beginning to unravel the mechanisms for doing so, using genetically engineered bacteria to target and destroy cancer cells.

The Conversation

“I Don’t Believe It”: Fans Suspicious After Gene Hackman Mystery Deepens With Doctor’s Statement

Dr. Josiah Child claims the pianist called his clinic on February 12, a day after authorities say she passed. The post “I Don’t Believe It”: Fans Suspicious After Gene Hackman Mystery Deepens With Doctor’s Statement first appeared on Bored Panda.

Bored Panda

Google AI solves 10-year problem in two days

Researchers say AI breakthrough is ‘game-changing’ for disease prevention

The Independent UK

Incyte Loses 9% As Skin Disease Drug Looks 'Viable, But Not Competitive'

Incyte's skin disease treatment looks "viable, but not competitive with biologics," an analyst said Monday as Incyte stock fell.

Investors Business Daily

Read news from The Economist, FT, and more,
with one subscription

Fewer deaths, new substances and evolving treatments in Philly’s opioid epidemic − 4 essential reads

In Philadelphia, fatal overdoses are the No. 3 cause of death after heart disease and cancer. That’s been the case each year since 2016, except in 2020 and 2021 when COVID-19 deaths outpaced overdose deaths. The vast majority of fatal overdoses in Philly involve the synthetic opioid fentanyl.

The Conversation

AstraZeneca pays up to $1bn for biotech firm ‘that could transform cell therapy’

UK pharma group acquires Belgium’s EsoBiotec as it announces EU has approved Imfinzi lung cancer drug

The Guardian - UK

Scientists may have finally developed pill to cure Ebola

Study also unravels drug’s mechanisms of action

The Independent UK

Long Covid is the pandemic’s dark shadow. Why does no one in power in Britain want to talk about it?

Five years after the first lockdown, millions of lives are still being ruined by this debilitating disease. You wouldn’t know it, says Guardian columnist Frances Ryan

The Guardian - UK

Scientists make major breakthrough in understanding cause of Parkinson’s

It could pave the way for developing drugs that stop or slow the disease’s progression

The Independent UK

Researchers Used Mosquitos To Deliver Malaria Vaccines

What if mosquitoes could deliver not just the disease but the protection to an infection that kills hundreds of thousands of people annually?

Reason

What Trump Has Done With Medicare So Far

Since President Trump was sworn into office on January 20, he has proposed or initiated changes impacting Medicare. Here's the latest roundup.

Kiplinger

Get all your
news in one place.

100’s of premium titles.
One news app.

Euronews

Having a poor socioeconomic background could speed up biological ageing, new study finds

For certain conditions, those who were more disadvantaged had twice as high a risk of developing age-associated diseases.

Pedestrian.tv

Measles Alert Hits Melbourne’s Nightlife: Popular Bars & Clubs Named In Fresh Outbreak

Multiple Melbourne nightclubs have been named in a measles outbreak warning in Victoria. Here are the details

Reason

Are COVID-19 Vaccines Safe and Effective?

Five years after Donald Trump declared a national COVID-19 emergency, here's what the research says.

Fortune

Dr. Oz says probiotic supplements have wide-ranging health benefits. Here's what science says

To aid in gut health, Oz has pushed the benefits of probiotics. Do they really work?

Get all your
news in one place.

100’s of premium titles.
One news app.

The Independent UK

Gene Hackman left his children out of will, leaving fate of $80m fortune uncertain

Hackman left his entire estate to his late wife, Betsy Arakawa

The Conversation

Treatment for Parkinson’s disease and restless leg syndrome is linked with risky behaviour – here’s what you need to know

Getting a headache and feeling sick are common side-effects for many medicines. Indulging in risky sexual behaviour or pathological gambling – not so common.

Salon

The lessons we didn't learn from COVID

The pandemic accelerated economic disparity, revealing a disturbing acceptance of mass death. Did we learn nothing?

The Conversation

Simple strategies can boost vaccination rates for adults over 65 − new study

Knowing which vaccines older adults should get and hearing a clear recommendation from their health care provider about why a particular vaccine is important strongly motivated them to get vaccinated. That’s a key finding in a recent study I co-authored in the journal Open Forum Infectious Diseases.

Barchart

Gilead Sciences - Leader in HIV Medicines

Summary Gilead Sciences (GILD) shows strong technical buy signals, with a 19.60% gain since Trend Seeker's buy signal on 1/27 and a 50.31% gain in the last year. The company offers a diverse portfolio of medicines for HIV, COVID-19, liver diseases, oncology, and more, with significant collaborations enhancing its pipeline....

Evening Standard

Gene Hackman's $80million fortune revealed as details of Hollywood star's will emerge

Gene Hackman last signed his will in 2005, and it has been revealed who he left his fortune to

Homes & Gardens

This is your last chance to prune oak trees to avoid a potentially fatal disease that can kill trees within months, arborists reveal

Stay safe and discover what you can prune at different times of the year

1 … 9 10 11 12

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Imperial College London

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.